Patents by Inventor Daiwei CHEN

Daiwei CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene expression signatures predictive of subject response to a multi-kinase inhibitor and methods of using the same
    Patent number: 11136625
    Abstract: Gene expression signature predictive of cancer patient response to multi-kinase inhibitor is disclosed. Also disclosed are methods predicting the efficacy of the multi-kinase inhibitor for treating cancer in a patient. Also disclosed are methods for distinguishing responders from non-responders to a multi-kinase inhibitor in treating cancer. Also disclosed are methods for treating a cancer patient with a multi-kinase inhibitor.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: October 5, 2021
    Assignee: CROWN BIOSCIENCE, INC. (TAICANG)
    Inventors: Sheng Guo, Daiwei Chen, Juan Zhang, Jie Cai, Henry Qixiang Li
  • GENE EXPRESSION SIGNATURES PREDICTIVE OF SUBJECT RESPONSE TO A MULTI-KINASE INHIBITOR AND METHODS OF USING THE SAME
    Publication number: 20160208328
    Abstract: Gene expression signature predictive of cancer patient response to multi-kinase inhibitor is disclosed. Also disclosed are methods predicting the efficacy of the multi-kinase inhibitor for treating cancer in a patient. Also disclosed are methods for distinguishing responders from non-responders to a multi-kinase inhibitor in treating cancer. Also disclosed are methods for treating a cancer patient with a multi-kinase inhibitor.
    Type: Application
    Filed: August 28, 2014
    Publication date: July 21, 2016
    Applicant: Crown Bioscience, Inc. (Taicang)
    Inventors: Sheng GUO, Daiwei CHEN, Juan ZHANG, Jie CAI, Henry Qixiang LI